Research location
West Hills
California, United States
Advertisement
Research activity in West Hills
California, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 130 trials and 132 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in West Hills
130 linked trials · page 2 of 3Study of KD026 in Combination With Metformin in Subjects With Type 2 Diabetes MellitusNCT02434744 · 2015-04-01 · 1 site observation
COMPLETED
Add Glucokinase Activator to Target A1cNCT02405260 · 2015-03-01 · 1 site observation
COMPLETED
Study of Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Rheumatoid Arthritis RemissionNCT02373813 · 2015-02-20 · 1 site observation
COMPLETED
AZD9291 Versus Gefitinib or Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung CancerNCT02296125 · 2014-12-03 · 1 site observation
COMPLETED
Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes MellitusNCT02229227 · 2014-11-21 · 1 site observation
COMPLETED
Study of Gelesis100 on Body Weight in Overweight and Obese Subjects With and Without Type 2 DiabetesNCT02307279 · 2014-11-01 · 1 site observation
COMPLETED
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes MellitusNCT02229383 · 2014-09-06 · 1 site observation
COMPLETED
Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 2 Diabetes Mellitus Patients (INSTRIDE 2)NCT02227875 · 2014-08-01 · 1 site observation
COMPLETED
Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DMNCT02058147 · 2014-02-01 · 1 site observation
COMPLETED
A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk FactorsNCT02019264 · 2014-01-24 · 1 site observation
COMPLETED
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 DiabetesNCT02058160 · 2014-01-01 · 1 site observation
COMPLETED
Phase 3 Study of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Late-stage Non-squamous Non-small-cell Lung CancerNCT01999673 · 2013-12-01 · 1 site observation
COMPLETED
Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast CancerNCT01997333 · 2013-11-01 · 1 site observation
COMPLETED
Dose-finding Study of GLPG0634 as Monotherapy in Active Rheumatoid Arthritis (RA) Participants (DARWIN2)NCT01894516 · 2013-10-08 · 1 site observation
COMPLETED
Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)NCT01942135 · 2013-09-26 · 1 site observation
COMPLETED
Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Participants (DARWIN1)NCT01888874 · 2013-07-17 · 1 site observation
COMPLETED
TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 DiabetesNCT01829464 · 2013-05-01 · 1 site observation
TERMINATED
A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)NCT01740427 · 2013-02-22 · 1 site observation
COMPLETED
Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes MellitusNCT01652729 · 2013-02-01 · 1 site observation
COMPLETED
Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic PatientsNCT01768559 · 2013-01-01 · 1 site observation
COMPLETED
A Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus Who Have Not Previously Received Anti-Hyperglycemic TherapyNCT01691755 · 2012-11-01 · 1 site observation
COMPLETED
A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin AloneNCT01691846 · 2012-10-01 · 1 site observation
COMPLETED
A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773) (Once Daily Versus Twice Daily) in Patients With Type 2 Diabetes Mellitus and Preexisting Metformin TherapyNCT01649297 · 2012-10-01 · 1 site observation
COMPLETED
A Long-Term Extension Study of WA22762 and NA25220 of Subcutaneous (SC) Tocilizumab (TCZ) in Moderate to Severe Rheumatoid Arthritis (RA)NCT01662063 · 2012-08-01 · 1 site observation
COMPLETED
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)NCT01621178 · 2012-07-01 · 1 site observation
COMPLETED
Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)NCT01601704 · 2012-06-01 · 1 site observation
TERMINATED
Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 DiabetesNCT01619059 · 2012-06-01 · 1 site observation
COMPLETED
A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin AloneNCT01555164 · 2012-06-01 · 1 site observation
COMPLETED
Evaluation of Glycemic Control Using Adjunctive Continuous Glucose Monitoring With the Dexcom G4 SystemNCT01627210 · 2012-05-01 · 1 site observation
COMPLETED
Comparison of Fasiglifam (TAK-875) to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 DiabetesNCT01549964 · 2012-04-01 · 1 site observation
TERMINATED
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy PatientsNCT01487109 · 2012-01-01 · 1 site observation
COMPLETED
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes MellitusNCT01494987 · 2012-01-01 · 1 site observation
COMPLETED
Ranolazine Monotherapy in Subjects With Type 2 Diabetes MellitusNCT01472185 · 2011-11-01 · 1 site observation
COMPLETED
Comparison of Technosphere® Insulin Versus Technosphere Powder (Placebo) in Insulin-Naive Subjects With Type 2 Diabetes MellitusNCT01451398 · 2011-11-01 · 1 site observation
COMPLETED
Combination of Nebivolol and Valsartan Given as Free Tablets for Stage 1 or Stage 2 HypertensionNCT01415505 · 2011-08-01 · 1 site observation
COMPLETED
NBRST: Prospective Neo-adjuvant REGISTRY TrialNCT01479101 · 2011-07-01 · 2 site observations
COMPLETED
12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes MellitusNCT01370005 · 2011-06-01 · 1 site observation
COMPLETED
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid ArthritisNCT01232569 · 2011-03-01 · 1 site observation
COMPLETED
Safety and Efficacy of Empagliflozin (BI 10773) and Sitagliptin Versus Placebo Over 76 Weeks in Patients With Type 2 DiabetesNCT01289990 · 2011-02-01 · 1 site observation
COMPLETED
Efficacy and Safety of Empagliflozin (BI 10773) in Type 2 Diabetes Patients on a Background of Pioglitazone Alone or With MetforminNCT01210001 · 2010-09-01 · 1 site observation
COMPLETED
Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 DiabetesNCT01167881 · 2010-08-01 · 1 site observation
COMPLETED
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor BlockerNCT01137474 · 2010-07-01 · 1 site observation
COMPLETED
Efficacy and Safety of Empagliflozin (BI 10773) Versus Placebo and Sitagliptin Over 24 Weeks in Patients With Type 2 DiabetesNCT01177813 · 2010-07-01 · 1 site observation
COMPLETED
A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.NCT01098539 · 2010-05-01 · 1 site observation
COMPLETED
A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.NCT01128894 · 2010-05-01 · 1 site observation
COMPLETED
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone AloneNCT01089790 · 2010-03-01 · 1 site observation
TERMINATED
Dapagliflozin DPPIV Inhibitor add-on StudyNCT00984867 · 2009-10-01 · 1 site observation
COMPLETED
A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin GlargineNCT00976391 · 2009-09-01 · 1 site observation
COMPLETED
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With PioglitazoneNCT00970424 · 2009-08-01 · 1 site observation
TERMINATED
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without MetforminNCT00947557 · 2009-07-01 · 1 site observation
TERMINATED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.